AGO2 and prostate carcinoma: Prior CLIP-Seq analysis revealed that PTBP1 binds to the 3′UTR of MCL1 (49), and we have shown that this enhances miR-101 targeting and subsequent AGO2-mediated degradation in the prostate cancer cell line PC3 (50).